Guo Wei, Zeng Mingyong, Zhu Suqin, Li Shiyang, Qian Yilin, Wu Haohao
School of Pharmacy, Binzhou Medical University, 346 Guanhai Road, Yantai, Shandong, 264003, China.
College of Food Science and Engineering, Ocean University of China, 5 Yushan Road, Qingdao, Shandong, 266003, China.
Food Funct. 2022 Mar 21;13(6):3294-3307. doi: 10.1039/d1fo02970c.
Phycocyanin is a typical microalgal active compound with antioxidant and anti-inflammatory efficacy, and the pigment moiety phycocyanobilin has been recently proposed as its active structural component. Here, to explore the structural basis for phycocyanin's intestinal protective action, we evaluated the therapeutic effects and mechanism of action of phycocyanin and phycocyanobilin in dextran sodium sulphate (DSS)-induced colitis mice and in Caco-2 and RAW 264.7 cells. Phycocyanobilin was obtained by solvothermal alcoholysis of phycocyanin and characterized by spectroscopy and mass spectrometry methods. Phycocyanin, phycocyanobilin and a positive drug mesalazine were intragastrically administered to C57BL/6 mice daily for 7 days during and after 4-day DSS exposure. Clinical signs and colon histopathology revealed that phycocyanin and phycocyanobilin had an equivalent anti-colitis efficacy that was even superior to mesalazine. Based on biochemical analysis of colonic tight junction proteins, mucus compositions and goblet cells, and colonic and peripheral proinflammatory cytokines, phycocyanin and phycocyanobilin displayed equivalent intestinal epithelial barrier-protecting and anti-inflammatory potential that was evidently superior to that of mesalazine. Flow cytometry analysis of phycocyanobilin fluorescence in Caco-2 cells unveiled a similar uptake efficacy of phycocyanin and phycocyanobilin by intestinal epithelial cells. According to lactic dehydrogenase release, 2',7'-dichlorodihydrofluorescein fluorescence and methylthiazolyldiphenyl-tetrazolium bromide assay in Caco-2 cells, phycocyanin and phycocyanobilin could equally and effectively protect the intestinal epithelial barrier from oxidant-induced disruption. Phycocyanin and phycocyanobilin also showed equivalent anti-inflammatory effects in tumor necrosis factor-α-stimulated Caco-2 cells and in lipopolysaccharides- and tumor necrosis factor-α-activated RAW264.7 cells. Overall, our results demonstrate the phycocyanobilin-dependent anti-colitis role of phycocyanin antioxidant and anti-inflammatory mechanisms.
藻蓝蛋白是一种具有抗氧化和抗炎功效的典型微藻活性化合物,其色素部分藻蓝胆素最近被认为是其活性结构成分。在此,为了探究藻蓝蛋白肠道保护作用的结构基础,我们评估了藻蓝蛋白和藻蓝胆素在葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠以及Caco-2细胞和RAW 264.7细胞中的治疗效果及作用机制。藻蓝胆素通过藻蓝蛋白的溶剂热醇解获得,并通过光谱和质谱方法进行表征。在4天DSS暴露期间及之后,每天对C57BL/6小鼠灌胃给予藻蓝蛋白、藻蓝胆素和阳性药物美沙拉嗪,持续7天。临床症状和结肠组织病理学显示,藻蓝蛋白和藻蓝胆素具有同等的抗结肠炎功效,甚至优于美沙拉嗪。基于对结肠紧密连接蛋白、黏液成分和杯状细胞以及结肠和外周促炎细胞因子的生化分析,藻蓝蛋白和藻蓝胆素表现出同等的肠道上皮屏障保护和抗炎潜力,明显优于美沙拉嗪。对Caco-2细胞中藻蓝胆素荧光的流式细胞术分析揭示了肠道上皮细胞对藻蓝蛋白和藻蓝胆素的摄取效果相似。根据Caco-2细胞中的乳酸脱氢酶释放、2',7'-二氯二氢荧光素荧光和甲基噻唑基二苯基四氮唑溴盐测定,藻蓝蛋白和藻蓝胆素能够同等有效地保护肠道上皮屏障免受氧化剂诱导的破坏。藻蓝蛋白和藻蓝胆素在肿瘤坏死因子-α刺激的Caco-2细胞以及脂多糖和肿瘤坏死因子-α激活的RAW264.7细胞中也表现出同等的抗炎作用。总体而言,我们的结果证明了藻蓝蛋白依赖藻蓝胆素的抗结肠炎作用及其抗氧化和抗炎机制。